Bicara CEO Claire Mazumdar sells 10,000 common shares for $283,440 - BCAX News | RalliesBicara CEO Claire Mazumdar sells 10,000 common shares for $283,440
B
BCAX• CEO exercises options and sells shares
- Bicara Therapeutics CEO Claire Mazumdar exercised stock options for 10,000 shares at $3.79 on July 10, 2026.
- She sold 10,000 shares the same day at an average $28.42, cutting her direct stake to 362,152 shares.
- Her remaining stock options totaled 120,546 shares following the transaction.
XLV
•
